Literature DB >> 10435583

Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis.

J Xaus1, M Cardó, A F Valledor, C Soler, J Lloberas, A Celada.   

Abstract

Incubation of bone marrow macrophages with lipopolysaccharide (LPS) or interferon gamma (IFN gamma) blocks macrophage proliferation. LPS treatment or M-CSF withdrawal arrests the cell cycle at early G1 and induces apoptosis. Treatment of macrophages with IFN gamma stops the cell cycle later, at the G1/S boundary, induces p21Waf1, and does not induce apoptosis. Moreover, pretreatment of macrophages with IFN gamma protects from apoptosis induced by several stimuli. Inhibition of p21Waf1 with antisense oligonucleotides or using KO mice shows that the induction of p21Waf1 by IFN gamma mediates this protection. Thus, IFN gamma makes macrophages unresponsive to apoptotic stimuli by inducing p21Waf1 and arresting the cell cycle at the G1/S boundary. Therefore, the cells of the innate immune system could only survive while they were functionally active.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10435583     DOI: 10.1016/s1074-7613(00)80085-0

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  56 in total

1.  IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice.

Authors:  C Herrero; L Marqués; J Lloberas; A Celada
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  p21-mediated RNR2 repression restricts HIV-1 replication in macrophages by inhibiting dNTP biosynthesis pathway.

Authors:  Awatef Allouch; Annie David; Sarah M Amie; Hichem Lahouassa; Loïc Chartier; Florence Margottin-Goguet; Françoise Barré-Sinoussi; Baek Kim; Asier Sáez-Cirión; Gianfranco Pancino
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-30       Impact factor: 11.205

3.  Increased immune response in mice consuming rice bran oil.

Authors:  Saleta Sierra; Federico Lara-Villoslada; Mónica Olivares; Jesús Jiménez; Julio Boza; Jordi Xaus
Journal:  Eur J Nutr       Date:  2005-02-22       Impact factor: 5.614

Review 4.  Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Authors:  Benjamin Weber; Leslie Saurer; Christoph Mueller
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

5.  Novel nuclear hENT2 isoforms regulate cell cycle progression via controlling nucleoside transport and nuclear reservoir.

Authors:  Natalia Grañé-Boladeras; Christopher M Spring; W J Brad Hanna; Marçal Pastor-Anglada; Imogen R Coe
Journal:  Cell Mol Life Sci       Date:  2016-06-06       Impact factor: 9.261

6.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

7.  p21Cip1 is required for the development of monocytes and their response to serum transfer-induced arthritis.

Authors:  John C Scatizzi; Jack Hutcheson; Emily Bickel; James M Woods; Karolina Klosowska; Terry L Moore; G Kenneth Haines; Harris Perlman
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

8.  Amniotic membrane induces apoptosis of interferon-gamma activated macrophages in vitro.

Authors:  Wei Li; Hua He; Tetsuya Kawakita; Edgar M Espana; Scheffer C G Tseng
Journal:  Exp Eye Res       Date:  2005-08-16       Impact factor: 3.467

9.  Interferon-gamma regulates nucleoside transport systems in macrophages through signal transduction and activator of transduction factor 1 (STAT1)-dependent and -independent signalling pathways.

Authors:  Concepció Soler; Antonio Felipe; José García-Manteiga; Maria Serra; Elena Guillén-Gómez; F Javier Casado; Carol MacLeod; Manuel Modolell; Marçal Pastor-Anglada; Antonio Celada
Journal:  Biochem J       Date:  2003-11-01       Impact factor: 3.857

10.  Interferon-gamma targets cancer cells and osteoclasts to prevent tumor-associated bone loss and bone metastases.

Authors:  Zhiqiang Xu; Michelle A Hurchla; Hongju Deng; Ozge Uluçkan; Fang Bu; Andrew Berdy; Mark C Eagleton; Emanuela A Heller; Desiree H Floyd; Wessel P Dirksen; Sherry Shu; Yuetsu Tanaka; Soledad A Fernandez; Thomas J Rosol; Katherine N Weilbaecher
Journal:  J Biol Chem       Date:  2008-12-05       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.